CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.
about
Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.Biofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype.Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone.Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities.Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea.Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe.Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in BrazilEvolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit.In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.Cooccurrence of Multiple AmpC β-Lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in TunisiaDraft Genome Sequence of Proteus mirabilis NO-051/03, Representative of a Multidrug-Resistant Clone Spreading in Europe and Expressing the CMY-16 AmpC-Type β-Lactamase.Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamaseCharacterization of CTX-M-140, a Variant of CTX-M-14 Extended-Spectrum β-Lactamase with Decreased Cephalosporin Hydrolytic Activity, from Cephalosporin-Resistant Proteus mirabilis.Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit.AmpC beta-lactamases.Virulence and Genomic Feature of a Virulent Klebsiella pneumoniae Sequence Type 14 Strain of Serotype K2 Harboring blaNDM-5 in China.Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.Chromosomal integration and location on IncT plasmids of the blaCTX-M-2 gene in Proteus mirabilis clinical isolates.Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones.Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings.Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 beta-lactamases.Colonization of long-term care facility residents in three Italian Provinces by multidrug-resistant bacteria.Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens
P2860
Q33601560-9B55A0A9-9A90-4C97-BF4A-37E7359C00ABQ33755384-1F978E2F-932D-4D6F-9FE3-496669C5A5C9Q33899961-BD57195F-13B2-4800-B24F-12F7DEEAE2FCQ34108605-71CEC188-8FF5-454C-8B94-02379882AE7EQ34623275-F53DC84F-202D-4210-ABEC-074C2E1BF822Q34737727-D5544358-376F-444C-B30C-04F3B40DC123Q35005180-44438B52-1E56-43B6-8133-0F0D74954932Q35065751-85485EB3-C732-4A7F-81B6-E3225DA54F1FQ35806283-3518BB3F-648D-4633-9CB9-A1A292560B73Q36290815-1FE15330-3FB4-4AF2-9144-3FAD03393762Q36439133-CC8B2E4B-2279-4091-8E54-A8571EF101C0Q36573826-2F8133D9-EA1D-493B-BDA9-BDB219525D66Q36744818-082AAE91-302D-4390-9124-59390D14990EQ36895636-93113FBD-C958-4531-93A1-97657FB524ACQ37247631-7CBB40A6-DA78-4980-9160-E7524D65E1B6Q37287849-C95206AB-CC28-4D65-9916-41E41BD13015Q37336188-BBB617C3-B101-44CB-97FE-423DBF93B251Q37366249-02767D1C-8A84-43DB-B0A1-E6C4BCE1AD8BQ37716730-F0061662-F811-41CD-906E-5EC1BAB97630Q39525501-ADD07C81-4DBB-4D25-8689-1B250EE30544Q40087078-3585EF6A-756C-4C41-AEE4-CF27B4004C10Q40601639-828F8420-C581-48CA-8DCE-B35F28D5CBC4Q43791115-FB8AA905-C888-44F4-9D70-7AC37B0A28D5Q46986700-2A480B70-CFE1-4BF4-A329-CEF99CFA01B7Q48079150-7539B661-CA9D-45BF-92E8-BD12838165DBQ52359703-C9AA4B60-5099-4C1F-A6E1-BDB6ED5D4F2BQ58797117-FD2E4A5D-BA1C-4A57-8F3C-5AF3D7D1857E
P2860
CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
CMY-16, a novel acquired AmpC- ...... mirabilis from northern Italy.
@en
CMY-16, a novel acquired AmpC- ...... mirabilis from northern Italy.
@nl
type
label
CMY-16, a novel acquired AmpC- ...... mirabilis from northern Italy.
@en
CMY-16, a novel acquired AmpC- ...... mirabilis from northern Italy.
@nl
prefLabel
CMY-16, a novel acquired AmpC- ...... mirabilis from northern Italy.
@en
CMY-16, a novel acquired AmpC- ...... mirabilis from northern Italy.
@nl
P2860
P50
P1476
CMY-16, a novel acquired AmpC- ...... mirabilis from northern Italy.
@en
P2093
Francesca Vailati
Vesselina Kroumova
P2860
P304
P356
10.1128/AAC.50.2.618-624.2006
P407
P50
P577
2006-02-01T00:00:00Z